-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 05/12/25 )
NAV
₹39.67
Last change
₹-0.02 -0.0%
Fund Size (AUM)
3143.91 Cr
Performance
16.26% (5Y)
Fund Details
DSP Healthcare Fund Regular Growth
as of 05/12/25
AUM
3143.91 Cr
Expense Ratio
1.91 %
Benchmark
BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Chirag Dagli
Exit Load
0.5% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | -4.67% | 20.77% | 16.26% |
| BSE Healthcare TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Cipla Ltd |
8.55% |
Sun Pharmaceuticals Industries Ltd |
8.26% |
Cohance Lifesciences Ltd |
7.11% |
Ipca Laboratories Ltd |
6.86% |
Laurus Labs Ltd |
6.73% |
Gland Pharma Ltd |
5.65% |
Sai Life Sciences Ltd |
5.23% |
Apollo Hospitals Enterprise Ltd |
4.76% |
Alembic Pharmaceuticals Ltd |
4.08% |
Kovai Medical Center & Hospital Ltd |
3.36% |
Sector Allocation
Healthcare |
98.45% |
Financial |
1.55% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
18.62% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
17.95% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
16.0% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
16.0% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
16.0% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
17.72% (5Y)
-
